Bicara Therapeutics Inc. (BCAX) has 10 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $1.8M. Most recent filing: Sept. 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 10, 2026 filed Sept. 8, 2026 | Cohlhepp Ryan President, COO & Interim CEO | $334,394 | 52,500 | 0% | Yes | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 12, 2026 | Larson Jennifer Chief Financial Officer | $0 | 285,000 | 0% | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | Cohlhepp Ryan President and COO | $453,474 | 56,250 | 0% | Yes | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | Mazumdar Claire Chief Executive Officer | $241,852 | 30,000 | 0% | Yes | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | Hyep Ivan Chief Financial Officer | $302,219 | 37,500 | 0% | Yes | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free